Announces Ted and
Kathee Kramm as Chief Executive Officer and President,
Respectively
PLANTATION, Fla., June 25,
2024 /PRNewswire/ -- BioMatrix Specialty
Infusion Pharmacy ("BioMatrix" or "The Company") announced today
the sale of the majority interests of the company from Acon
Investments & Triton Pacific Healthcare to Frazier Healthcare
Partners ("Frazier"). The company also announced the appointment of
Ted Kramm as its new Chief Executive
Officer, with Kathee Kramm assuming
the role of President. Terms of the transaction were not
disclosed.
![BioMatrix Specialty Infusion Pharmacy (PRNewsfoto/BioMatrix Specialty Infusion Pharmacy) BioMatrix Specialty Infusion Pharmacy (PRNewsfoto/BioMatrix Specialty Infusion Pharmacy)](https://mma.prnewswire.com/media/2406871/BioMatrix_Specialty_Infusion_Pharmacy_Logo.jpg)
Based in Seattle, Washington,
Frazier Healthcare Partners is a private equity firm focused
exclusively on the healthcare industry. Frazier partners with
strong management teams to execute on long-term organic and
inorganic growth strategies. Frazier has over 32 years of thematic
investing experience across the healthcare ecosystem, with a focus
on building great companies with a patient-centric approach to
care. Frazier's experience and differentiated Center of Excellence
will help BioMatrix continue to grow and provide exceptional
care.
Ted and Kathee Kramm are two of
the most notable and experienced executives in the home-infusion
market. As clinicians (Ted a pharmacist and Kathee a nurse), the
Kramm's have a proven track record of founding, establishing, and
growing leading home-infusion companies. Most notably, the duo
co-founded AxelaCare in 2008, growing it into one of the largest
providers of home-infusion services nationwide. Ted and Kathee
bring their expertise to BioMatrix to facilitate the continued
growth in the infusion pharmacy arena.
"Frazier is an ideal partner for the future of BioMatrix,"
stated Ted Kramm, incoming Chief
Executive Officer at BioMatrix. "Their reputation in healthcare
coupled with their inherent corporate values, commitment to their
people, investment strategies, and shared vision will propel
BioMatrix to new heights."
Kathee Kramm stated, "Since
joining Nick Karalis and the
BioMatrix leadership team in May
2023, I have had the absolute pleasure of getting to know a
group of people who roll up their sleeves on a daily basis to do
what's right for our patients. I am grateful to Nick for welcoming
me into the team and I look forward to integrating Frazier into the
BioMatrix family and culture. Together, we'll continue to grow and
expand upon our services to consistently put our patients
first."
"I am incredibly honored to have worked alongside the many
patient-focused and dedicated employees of BioMatrix," said
Nick Karalis, outgoing Chairman of
the Board and former Chief Executive Officer at BioMatrix. "I am
confident Ted and Kathee Kramm will
continue to embody the values that represent BioMatrix and Frazier
and I look forward to watching this company flourish under their
leadership."
Houlihan Lokey served as the
exclusive financial advisor to BioMatrix Specialty Infusion
Pharmacy.
About BioMatrix Specialty Infusion Pharmacy
BioMatrix Specialty Infusion Pharmacy, an Inc. 5000 company, is
a trusted, independent specialty infusion pharmacy with decades of
experience. Our compassionate care team helps patients navigate the
often-challenging healthcare environment. We work closely with our
patients, as well as their family and their healthcare providers,
throughout the patient's journey, staying focused on continuity of
care and optimal clinical outcomes. Every day, in every
interaction, we are dedicated to making a difference in people's
lives. For more information about BioMatrix, visit
www.biomatrixsprx.com.
About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a private equity
firm focused exclusively on the healthcare industry. Since its
inception, Frazier has raised over $8
billion of capital for private funds and co-investment
opportunities and has invested in more than 200 companies over 32
years. Frazier has a philosophy of partnering with strong
management teams while leveraging its internal operating resources
and network to build exceptional companies. Frazier is
headquartered in Seattle, WA, and
invests broadly across the U.S., Canada, and Europe. For more information about Frazier,
visit www.frazierhealthcare.com.
Media Contacts
BioMatrix Infusion
Pharmacy:
Tara Marchese,
Senior Director of Marketing
954-908-7636
tara.marchese@biomatrixsprx.com
Frazier Healthcare Partners:
Carol Eckert, VP of Investor Relations
206-621-7200
carol.eckert@frazierhealthcare.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biomatrix-specialty-infusion-pharmacy-acquired-by-frazier-healthcare-partners-302181238.html
SOURCE BioMatrix Specialty Infusion Pharmacy